Details of the Drug

General Information of Drug (ID: DMC89HI)

Drug Name
NM-9308
Synonyms
Bikaciomab; Bikaciomab (AMD), NovelMed Therapeutics; Complement factor B inhibitor (age related maculardegeneration), NovelMed Therapeutics; Anti-factor B monoclonal antibody (age related macular degenration), NovelMed Therapeutics
Indication
Disease Entry ICD 11 Status REF
Age-related macular degeneration 9B75.0 Investigative [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
D09PKZ

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Complement factor B (CFB) TTA0P7K CFAB_HUMAN Not Available [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Age-related macular degeneration
ICD Disease Classification 9B75.0
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Complement factor B (CFB) DTT CFB 1.63E-02 0.07 0.13
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2339).